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Information on serum proteins in inflammation during the neonatal period has developed significantly in recent years.Besides their diagnostic value in detecting bacterial infections, quantification of proteins in serum is important in assessing the effectiveness of antibiotic therapy.
Increases of C-reactive protein (CR?) in viral infections are rare, although orosomucoid (a1-acid glycoprotein) may be increased in certain cases.' In newborns or infants, increased CR? and orosomucoid in serum strongly indicates bacterial infection. Because such increases are significant and persistent, and because these two proteins are not transferred from the mother via the placenta, they appear to be the proteins most suited for monitoring bacterial infections (1) (2) (3) (4) .
In infections the concentration of CR? increases very rapidly, whereas the concentration of orosomucoid increases slowly as infection progresses. With effective antibiotic therapy the concentration of CR? rapidly decreases to normal values within 24 h, whereas orosomucoid decreases more slowly, over several days. In our pediatric biochemistry laboratory, the number of requests for determinations of serum CR? and orosomucoid (90 per week) justifies a fully automated method. Recently, turbidimetric endpoint methods for determining these proteins with a random-access analyzer have involved using only a single point for calibration (5, 6). To monitor the extremely low concentrations of these proteins in newborns, we considered that multipoint calibration would be necessary, given the classical sigmoidal response curve in antibody excess; use of a single calibrant at mid-range with extrapolation to zero concentration would overestimate low concentrations.
Recently, Ng et al. (7) reported that the Technicon BA-1000 random-access analyzer had good analytical performance for determining immunoglobulins by an endpoint turbidimetric method with multipoint calibration. We undertook the present study to determine whether the RA-1000 would provide satisfactory turbidimetric assays of these acute-phase proteins at low concentrations in pediatric samples. Antisera: Antisera to human CR? and human orosomucoid (Atlantic Antibodies, Scarborough, ME 04074) were diluted 11-fold andsevenfold, respectively, with PEG-PBS, then left to stand for 30 mm before use in the RA-1000. The diluted antisera, which need not be filtered, are stable for as long as five days at ambient temperature.
Materials and Methods

Instruments
Calibration: The RA-i000 was calibrated with calibratore, CA-i, 1.4 g/L, for orosomucoid; CA-7, 130 mgfL, for CR? (Atlantic Antibodies). The multipoint calibrations involved using six concentrations of orosomucoid, nine of CR?. The calibrators were diluted with PBS to 0,12.5,25,50,75, and 100% of their original concentration. Additionaldilutions of the calibrator for CR? of 6.25 and 3.12% were used. The calculated values for each standard were entered into the RA-1000 according to operating procedures. We tested the stabilityof the calibration curves by assaying three quality-control samples at different concentrations each day.
The ICS requires calibration at one concentration of calibratorat the beginning of each run, and every 2 h thereafter.
Samples: Samples were collected from newborns by heel puncture, with no preservative used. The resulting sera were analyzed within several hours or stored overnight at 4 to 8#{176}C.
Precision studies: To assess within-run precision, we analyzed three different pooled sera in batch mode. In the study of between-run precision, the sera were pooled and repeatedly analyzed over a two-week period.
Methods: Analytical settings of the RA-i000 are given in Table 1 . We determined the concentrations of the two 
Sera were placed on the RA-1000 sample tray and the instrument was set to aspirate 300 pL of PEG-PBS (reagent 1) for CR? and 330 L for orosomucoid, followed by addition of 30 &L of sample for CR? or 3 zL for orosomucoid. After 2.5 mm a blank absorbance reading at 340 nm was obtained just before 100 j.tL of diluted antibody (reagent 2) was added. This absorbance (sample blank) issubtracted from the final absorbancereading obtained 6 miii later.
The difference in absorbance at 340 nm between the final absorbance reading and the sample blank isproportional to the concentrations of CR? or orosomucoid.The RA-1000 printsthe results as concentration of the proteins.
For methods involving a single-point calibration, we used the same analytical settings as listed in Table 1 except that 0 (no) instead of 1 (yes) was entered for "Immunoassay." Changing this parameter obviates the use of multiple calibrants, and the calibration curve is based on zero concentration (sample blank) and the value of the single calibrant (130 mg/L for CR? and 1.40 g/L for orosomucoid).
Temperature: All assays were performed at 30#{176}C.
Results
Optimizing assay conditions:
In preliminary experiments we determined the concentrations of antigen and antibody optimal for the RA-1000. For CR? and orosomucoid, optimal dilutions of antibody were il-fold for CR? and sevenfold for orosomucoid, the respective sample volumes being 30 and3 L (Figures 1 and 2) . Use of undiluted samples means that both proteins can be assayed simultaneously, and no manual dilutions of sample are required.
Calibration: Once the RA-1000 has been calibrated, the calibration curve, stored in the microprocessor, is very stable. At most, recalibration is required once every two weeks. Routinely, we calibrate the analyzer when results for one of the two quality-control samples included in every analytical series exceeds 2 SD or when a different lot number of antiserum isused.The diluted calibrants are not stable for very long and must be freshly prepared for each calibration. The calibration curves for both orosomucoidand CR? are nonlinear.
Precision: Table 2 (5) .Our studies clearly show thata linear calibration curve for which only one-point calibration is used for an endpoint method gives highly inaccurate results. We highly recommend that endpoint turbidimetric immunoassays be performedwith instruments having multipoint calibration or that can compensate for nonlinearity, such as the ICS.
In contrast to the ICS system, which checks for antigen excess, the RA-l000 prints a result of "uuD," indicating that the value exceeds the analytical limit. Such samples are diluted fivefold with saline and re-analyzed. In routine analyses we foundno antigen excessto at least 350 mg/L of CR? and 2.20 g/L of orosomucoid-the highest concentrations encountered, and which were flagged on the RA-1000. Extremely high concentration of CR2 is due to a chronic inflammatory process that does not occur in newborns.
The presence of excessantigen would give falsely low results, but, because the two proteins are measured concurrently in all samples, the results serve as a control for antigen excess.That isto say, the concentrations of both proteins are increased in infections of newborns; thus a normal result for only one is highly improbable.
If one wishes to verify that all concentrations of protein are not in the zone of antigen excess,the RA-l000 can easily be programmed to perform two tests for eachprotein simultaneously. For example, one test for CR? is programmed to aspirate 30 pL of sample while 6 ,L is used in the second; dissimilar results of the two tests would indicate antigen excess. However, we do not consider this mode of operation necessary.
PEG, used in immunological reactions, increases their sensitivity and decreases reaction time (8). High concentrations of PEG precipitate some serum components that increase the absorbance and necessitate a sample-blank determination.
Lower concentration of PEG combined with sample-blankdetermination has been usedto overcome this nonspecificity (9). The serum blank in our methods is measured after calibrants or samples have been mixed with PEG for 2.5 miii, which corrects for the nonspecific turbidity, whether inherent in the sample or formed in the presence of PEG. Furthermore, this type of sample-blank determination negates a separate serum blank that would increase the sample volume required.
The analytical rate with the RA-1000 is good. Results for 60 determinations (30 CR? and 30 orosomucoid) are available in an hour. The first results are reported 8.5 miii after the first reagent is aspirated. The RA-i000 performs both tests on undiluted sera, simultaneously and automatically, in random-access mode and with little operator intervention.
The determinations of CR? and orosomucoid with use of the RA-1000 have been introduced successfully in our clinical laboratory. With stable reagents as well as calibration, these tests are performed easily in routine or emergency situation at any time. Our staff greatly appreciates the easy and efficient operation of the RA-1000.
